Carson Wealth (CWM LLC)’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Sell
3,259
-403
-11% -$13.5K ﹤0.01% 3192
2025
Q4
$127K Buy
3,662
+269
+8% +$8.58K ﹤0.01% 2892
2025
Q3
$92K Buy
3,393
+240
+8% +$5.8K ﹤0.01% 3044
2025
Q2
$66K Buy
3,153
+782
+33% +$15K ﹤0.01% 3059
2025
Q1
$39K Buy
2,371
+1,814
+326% +$38.6K ﹤0.01% 3184
2024
Q4
$14K Buy
557
+76
+16% +$2.15K ﹤0.01% 3675
2024
Q3
$15K Buy
481
+69
+17% +$2.62K ﹤0.01% 3542
2024
Q2
$14K Buy
412
+12
+3% +$475 ﹤0.01% 3343
2024
Q1
$18K Buy
400
+2
+0.5% +$86 ﹤0.01% 2969
2023
Q4
$14K Sell
398
-92
-19% -$2.75K ﹤0.01% 2989
2023
Q3
$13K Buy
490
+92
+23% +$2.33K ﹤0.01% 2982
2023
Q2
$9K Hold
398
﹤0.01% 3136
2023
Q1
$5K Hold
398
﹤0.01% 3297
2022
Q4
$7K Hold
398
﹤0.01% 3005
2022
Q3
$6K Buy
+398
New +$5.17K ﹤0.01% 2974

Other funds holding IDYA

Carson Wealth (CWM LLC)'s IDYA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its IDEAYA Biosciences (IDYA) stake by 11% in Q1 2026, selling an estimated $13.5K and leaving 3,259 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

Carson Wealth (CWM LLC) first reported a position in IDYA in Q3 2022 and has held it in 15 quarters since. The position peaked at $127K in Q4 2025. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 3,259 shares of IDEAYA Biosciences worth $109K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 403 IDEAYA Biosciences shares in Q1 2026, an estimated $13.5K.
  • IDEAYA Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3192 holding.
  • Carson Wealth (CWM LLC) first reported a position in IDEAYA Biosciences in Q3 2022 and has held it in 15 quarters since.
  • Carson Wealth (CWM LLC)'s IDEAYA Biosciences position peaked at $127K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.